These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 9597295)

  • 1. Neurofibromatosis type 1 in childhood: evaluation of clinical and epidemiologic features as predictive factors for severity.
    Zvulunov A; Weitz R; Metzker A
    Clin Pediatr (Phila); 1998 May; 37(5):295-9. PubMed ID: 9597295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neurofibromatosis type 1: more frequent and severe then usually thought].
    Souza JF; Toledo LL; Ferreira MC; Rodrigues LO; Rezende NA
    Rev Assoc Med Bras (1992); 2009; 55(4):394-9. PubMed ID: 19750304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does the presence of dystrophic features in patients with type 1 neurofibromatosis and spinal deformities increase the risk of surgery?
    Lykissas MG; Schorry EK; Crawford AH; Gaines S; Rieley M; Jain VV
    Spine (Phila Pa 1976); 2013 Aug; 38(18):1595-601. PubMed ID: 23680833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective evaluation of the brain in asymptomatic children with neurofibromatosis type 1: relationship of macrocephaly to T1 relaxation changes and structural brain abnormalities.
    Steen RG; Taylor JS; Langston JW; Glass JO; Brewer VR; Reddick WE; Mages R; Pivnick EK
    AJNR Am J Neuroradiol; 2001 May; 22(5):810-7. PubMed ID: 11337320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurofibromatosis type 1: update on a common genetic condition.
    Siqveland E; Pond D
    Minn Med; 2009 Mar; 92(3):49-52. PubMed ID: 19400389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations of clinical features in neurofibromatosis 1 (NF1).
    Szudek J; Birch P; Riccardi VM; Evans DG; Friedman JM
    Genet Epidemiol; 2000 Dec; 19(4):429-39. PubMed ID: 11108651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and mutational spectrum of neurofibromatosis type 1-like syndrome.
    Messiaen L; Yao S; Brems H; Callens T; Sathienkijkanchai A; Denayer E; Spencer E; Arn P; Babovic-Vuksanovic D; Bay C; Bobele G; Cohen BH; Escobar L; Eunpu D; Grebe T; Greenstein R; Hachen R; Irons M; Kronn D; Lemire E; Leppig K; Lim C; McDonald M; Narayanan V; Pearn A; Pedersen R; Powell B; Shapiro LR; Skidmore D; Tegay D; Thiese H; Zackai EH; Vijzelaar R; Taniguchi K; Ayada T; Okamoto F; Yoshimura A; Parret A; Korf B; Legius E
    JAMA; 2009 Nov; 302(19):2111-8. PubMed ID: 19920235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurofibromatosis type 1 clinical features and management.
    Scalzone M; Coccia P; Ruggiero A; Riccardi R
    Pediatr Med Chir; 2009; 31(6):246-51. PubMed ID: 20333883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Encephalic lesions in neurofibromatosis: clinical manifestations and typical magnetic resonance findings].
    Magnaldi S; White RM; Bryan RN
    Radiol Med; 1990 Dec; 80(6):796-807. PubMed ID: 2126389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discounting an adverse maternal effect on severity of neurofibromatosis.
    Riccardi VM; Wald JS
    Pediatrics; 1987 Mar; 79(3):386-93. PubMed ID: 3103092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of neurofibromatosis type 1 on children's development.
    Haynes NM; Kirwan JR; McCrohan K
    Soc Work Public Health; 2011; 26(4):444-53. PubMed ID: 21707352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial neurofibromatosis type 1: clinical experience with DNA testing.
    Hofman KJ; Boehm CD
    J Pediatr; 1992 Mar; 120(3):394-8. PubMed ID: 1347082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between moyamoya syndrome and the RNF213 c.14576G>A variant in patients with neurofibromatosis Type 1.
    Phi JH; Choi JW; Seong MW; Kim T; Moon YJ; Lee J; Koh EJ; Ryu SK; Kang TH; Bang JS; Oh CW; Park SS; Lee JY; Wang KC; Kim SK
    J Neurosurg Pediatr; 2016 Jun; 17(6):717-22. PubMed ID: 26849809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health supervision for children with neurofibromatosis.
    Hersh JH;
    Pediatrics; 2008 Mar; 121(3):633-42. PubMed ID: 18310216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neurofibromatosis in children. Our experience].
    López-Pisón J; Cuadrado-Martín M; Boldova-Aguar MC; Muñoz-Mellado A; Cabrerizo de Diago R; Peña-Segura JL
    Rev Neurol; 2003 Nov 1-15; 37(9):820-5. PubMed ID: 14606048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A genetic study of von Recklinghausen neurofibromatosis in south east Wales. I. Prevalence, fitness, mutation rate, and effect of parental transmission on severity.
    Huson SM; Compston DA; Clark P; Harper PS
    J Med Genet; 1989 Nov; 26(11):704-11. PubMed ID: 2511318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of neurofibromatosis type 1.
    Friedman JM
    Am J Med Genet; 1999 Mar; 89(1):1-6. PubMed ID: 10469430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association of neurofibromatosis type 1 and attention deficit hyperactivity disorder.
    Koth CW; Cutting LE; Denckla MB
    Child Neuropsychol; 2000 Sep; 6(3):185-94. PubMed ID: 11402396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurofibromatosis in children with soft tissue sarcoma.
    Hartley AL; Birch JM; Marsden HB; Harris M; Blair V
    Pediatr Hematol Oncol; 1988; 5(1):7-16. PubMed ID: 3155239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neurofibromatosis type I--the pediatric endocrinologist's point of view].
    Januś D; Wójcik M; Kalicka-Kasperczyk A; Roztoczyńska D; Wojtyś J; Tyrawa K; Dolezal-Ołtarzewska K; Wcisło B; Was M; Starzyk J
    Przegl Lek; 2010; 67(11):1155-9. PubMed ID: 21442968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.